Gerresheimer AG Adjusts Financial Forecasts for 2025 Amid Slowed Market Growth

On October 8, 2025, Gerresheimer AG announced a downward revision of its financial forecast for 2025, citing weaker than expected business performance and slow market growth. The company, based in Duesseldorf, revealed that subdued demand in cosmetic and oral liquid medication containment markets has impacted its third-quarter results.

Preliminary figures indicate a revenue of EUR 560.7 million and an adjusted EBITDA of EUR 103.4 million for the quarter, with a -1.2% decline in organic revenue growth. As a result, Gerresheimer expects a decrease in organic revenue by 2% to 4% for the year, coupled with an adjusted EBITDA margin between 18.5% and 19%.

To counteract these challenges, Gerresheimer is initiating cost-reduction measures and a comprehensive transformation program aimed at enhancing performance and cash flow. This includes optimizing investment plans and improving operational efficiency. A newly established Transformation Office will oversee these initiatives.